PMID: 6991332May 1, 1980Paper

Pirogliride: an oral hypoglycemic drug which accelerates glucose usage and insulin secretion by islets of Langerhans

Diabetes
W S ZawalichF M Matschinsky

Abstract

Pirogliride potentiates glucose-induced insulin secretion from isolated islets. This effect is accompanied by a facilitated glucose metabolism. Pirogliride partially prevents the known inhibitory effects of mannoheptulose on glucose-induced secretion and utilization. Pirogliride might be useful not only to probe the underlying mechanism of stimulated insulin secretion but also in the therapy of those diabetics who have an impaired beta-cell responsiveness to glucose.

Citations

Jul 8, 1985·Life Sciences·H S Bender, W R Chickering
Jan 1, 1989·Pharmacology & Therapeutics·C J BaileyV Marks
Jul 31, 1998·Journal of Pharmaceutical and Biomedical Analysis·W N Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Related Papers

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme
W S ZawalichF M Matschinsky
The Journal of Pharmacology and Experimental Therapeutics
W S ZawalichS Cote
© 2021 Meta ULC. All rights reserved